Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and 'People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.